AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Alexander Semenov

Alexander G. Semenov

Alexander G. Semenov, PhD, a project manager in R&D department of Finnish biotech company HyTest - a producer of monoclonal antibodies and antigens for the diagnostic industry and research communities.

Alexander G. Semenov graduated from Moscow State University majored in biochemistry and received PhD in biochemistry from the same university. Since 2005 he has been involved in research projects of HyTest focused on B-type natriuretic peptide (BNP) and BNP-related peptides. The results of these studies were presented at high-level conferences and published in high impact international journals (e.g. Clinical Chemistry, Clinical Biochemistry).


Scientific Shorts